You are here

kidney translants

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Drugs.com

Tue, 03/11/25 - 06:57 pm

clinical trials

kidney translants

Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients

Pharmabiz.com

Tue, 12/31/13 - 11:36 am

kidney translants